Healthcare resource utilization and costs among children with cystic fibrosis in the United States-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Healthcare resource utilization and costs among children with cystic fibrosis in the United States

Published:2021-07-07 Issue:9 Volume:56 Page:2833-2844
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatric Pulmonology

Author:

Thorat Teja¹^ORCID,McGarry Lisa J.¹,Bonafede Machaon M.²³,Limone Brendan L.³,Rubin Jaime L.¹,Jariwala‐Parikh Krutika³,Konstan Michael W.⁴⁵^ORCID

Affiliation:

1. Vertex Pharmaceuticals Incorporated Boston Massachusetts USA

2. Veradigm Life Sciences, an Allscripts Healthcare LLC Chicago Illinois USA

3. Life Sciences, IBM Watson Health Cambridge Massachusetts USA

4. Department of Pediatrics Case Western Reserve University School of Medicine Cleveland Ohio USA

5. Department of Pediatrics Rainbow Babies and Children's Hospital Cleveland Ohio USA

Funder

Vertex Pharmaceuticals

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.25535

Reference41 articles.

1. Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA

2. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation

3. Cystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatment

4. Lung Disease at Diagnosis in Infants with Cystic Fibrosis Detected by Newborn Screening

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Specialists in Care Integration: A Primary Responsibility;The Journal of Pediatrics;2024-08

2. “I eat chocolate milk for dinner because we just have nothing in our fridge”: The invisible burden and dire consequences of food insecurity for people with cystic fibrosis in the United States;Pediatric Pulmonology;2024-07-23

3. Cystic fibrosis patient characteristics and healthcare resource utilization in Finland using linked registries;Heliyon;2024-07

4. Measuring the burden of cystic fibrosis: A scoping review;Journal of Cystic Fibrosis;2023-12

5. Impact of Elexacaftor/Tezacaftor/Ivacaftor on Healthcare Resource Utilization and Associated Costs Among People With Cystic Fibrosis in the US: A Retrospective Claims Analysis;Pulmonary Therapy;2023-10-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3